Cleared Traditional

GORE Tri-Lumen Catheter (K180919) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K180919 · W. L. Gore and Associates, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2018
Decision
179d
Days
Class 2
Risk

K180919 is an FDA 510(k) clearance for the GORE Tri-Lumen Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by W. L. Gore and Associates, Inc. (Flagstaff, US). The FDA issued a Cleared decision on October 5, 2018 after a review of 179 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all W. L. Gore and Associates, Inc. devices

Submission Details

510(k) Number K180919 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 09, 2018
Decision Date October 05, 2018
Days to Decision 179 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
54d slower than avg
Panel avg: 125d · This submission: 179d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 316
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K180919.
Tractus Crossing Support Catheter
K180889 · Tractus Vascular, LLC · Dec 2018
React 71 Catheter
K182097 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Nov 2018
Teleport Microcatheter
K182360 · Orbusneich Medical Trading, Inc. · Nov 2018
The ARTERIAL WAND Safety Introducer with Arterial Catheter made of ChronoFlex C with BioGUARD Technology
K181563 · Access Scientific, LLC · Sep 2018
SelectFlex 072 Neurovascular Access System
K181000 · Q'Apel · Sep 2018
EagleRay Long Sheath, 0.088 ID, 80cm, 90cm, 100cm and 110cm Lengths, EagleRay Access Catheter, 0.071 ID, 137cm Length, EagleRay Access Catheter, 0.055 ID, 137cm Length, EagleRay Access Catheter, 0.045 ID, 144cm Length, EagleRay Access Catheter, 0.035 ID, 158cm Length
K180169 · Imperative Care, Inc. · Aug 2018